Forbes McGain

7.6k total citations · 3 hit papers
114 papers, 3.2k citations indexed

About

Forbes McGain is a scholar working on Health, Toxicology and Mutagenesis, General Health Professions and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Forbes McGain has authored 114 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Health, Toxicology and Mutagenesis, 38 papers in General Health Professions and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Forbes McGain's work include Climate Change and Health Impacts (62 papers), Healthcare cost, quality, practices (29 papers) and Infection Control and Ventilation (15 papers). Forbes McGain is often cited by papers focused on Climate Change and Health Impacts (62 papers), Healthcare cost, quality, practices (29 papers) and Infection Control and Ventilation (15 papers). Forbes McGain collaborates with scholars based in Australia, United States and United Kingdom. Forbes McGain's co-authors include Scott McAlister, David Story, Jodi D. Sherman, Manfred Lenzen, Arunima Malik, Alexandra Barratt, Chris Naylor, Cathy Lawson, Jane Muret and Katy Bell and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Environmental Science & Technology.

In The Last Decade

Forbes McGain

102 papers receiving 3.1k citations

Hit Papers

The carbon footprint of Australian health care 2018 2026 2020 2023 2018 2020 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Forbes McGain Australia 30 2.0k 1.2k 774 394 275 114 3.2k
Jodi D. Sherman United States 30 3.3k 1.6× 1.7k 1.4× 979 1.3× 596 1.5× 409 1.5× 66 4.6k
Cassandra L. Thiel United States 28 1.5k 0.7× 900 0.8× 603 0.8× 311 0.8× 130 0.5× 78 2.4k
Scott McAlister Australia 15 942 0.5× 577 0.5× 282 0.4× 221 0.6× 76 0.3× 35 1.3k
Graciela Mentz United States 30 898 0.5× 760 0.6× 608 0.8× 87 0.2× 136 0.5× 116 3.2k
Mario Merialdi Switzerland 44 389 0.2× 832 0.7× 1.3k 1.6× 141 0.4× 396 1.4× 109 7.0k
Ana Pilar Betrán Switzerland 49 297 0.1× 1.4k 1.2× 2.6k 3.4× 222 0.6× 366 1.3× 183 12.4k
Homero Martı́nez Mexico 31 334 0.2× 653 0.6× 637 0.8× 69 0.2× 89 0.3× 138 3.3k
Ray Copes Canada 39 3.0k 1.5× 296 0.3× 246 0.3× 88 0.2× 506 1.8× 88 4.8k
Marianne C. Fahs United States 30 380 0.2× 661 0.6× 289 0.4× 264 0.7× 184 0.7× 75 2.6k
Tobias Alfvén Sweden 28 1.2k 0.6× 277 0.2× 255 0.3× 83 0.2× 203 0.7× 133 3.2k

Countries citing papers authored by Forbes McGain

Since Specialization
Citations

This map shows the geographic impact of Forbes McGain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Forbes McGain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Forbes McGain more than expected).

Fields of papers citing papers by Forbes McGain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Forbes McGain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Forbes McGain. The network helps show where Forbes McGain may publish in the future.

Co-authorship network of co-authors of Forbes McGain

This figure shows the co-authorship network connecting the top 25 collaborators of Forbes McGain. A scholar is included among the top collaborators of Forbes McGain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Forbes McGain. Forbes McGain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bagenal, Jessamy, Matthew J. Eckelman, Jacob Fry, et al.. (2025). The Lancet MedZero: carbon analytics for health care, by health care, at scale. The Lancet. 407(10525). 205–207. 1 indexed citations
2.
McAlister, Scott, John Knight, Forbes McGain, et al.. (2024). The Carbon Footprint of Peritoneal Dialysis in Australia. Journal of the American Society of Nephrology. 35(8). 1095–1103. 14 indexed citations
3.
McAlister, Scott, et al.. (2024). Environmental and financial impacts of perioperative paracetamol use: a multicentre international life-cycle assessment. British Journal of Anaesthesia. 133(6). 1439–1448. 11 indexed citations
4.
Fletcher, Robert A., Bruce Neal, Megumi Oshima, et al.. (2024). The potential for reducing greenhouse gas emissions through disease prevention: a secondary analysis of data from the CREDENCE trial. The Lancet Planetary Health. 8(12). e1055–e1064. 5 indexed citations
5.
Anstey, Matthew, et al.. (2023). How often are infusion sets for central venous catheters changed in Australian and New Zealand Intensive Care Units? A point prevalence survey. Australian Critical Care. 37(3). 495–498. 3 indexed citations
6.
Chatterjee, Debnath, et al.. (2023). It's time to stop using nitrous oxide for pediatric mask induction. Pediatric Anesthesia. 34(2). 104–107. 5 indexed citations
7.
Harris, Roger C., et al.. (2022). Everyone’s a winner if we test less: the CODA action plan. Australian Health Review. 46(4). 460–462. 5 indexed citations
8.
McGain, Forbes, et al.. (2021). Carbon Footprint of General, Regional, and Combined Anesthesia for Total Knee Replacements. Anesthesiology. 135(6). 976–991. 71 indexed citations
9.
Shrimpton, Andrew, Jeremy Brown, Florence K. A. Gregson, et al.. (2021). Quantitative evaluation of aerosol generation during manual facemask ventilation. Anaesthesia. 77(1). 22–27. 10 indexed citations
10.
McGain, Forbes, et al.. (2021). A prospective clinical evaluation of a patient isolation hood during the COVID-19 pandemic. Australian Critical Care. 35(1). 28–33. 3 indexed citations
11.
Litton, Edward, Helen Atkinson, James Anstey, et al.. (2021). Optimising a targeted test reduction intervention for patients admitted to the intensive care unit: The Targeted Intensive Care Test Ordering Cluster Trial intervention. Australian Critical Care. 34(5). 419–426. 5 indexed citations
12.
Abrahams, Brendan F., Ravichandar Babarao, Timothy A. Hudson, et al.. (2020). The Effect of Sterically Active Ligand Substituents on Gas Adsorption within a Family of 3D Zn-Based Coordination Polymers. Inorganic Chemistry. 59(13). 8871–8881. 9 indexed citations
13.
Glassford, Neil J., Jai N. Darvall, Andrew Casamento, et al.. (2018). Ventilation management in Victorian intensive care unit patients without acute respiratory distress syndrome. Critical Care and Resuscitation. 20(2). 101–e4. 2 indexed citations
14.
McGain, Forbes, et al.. (2018). Smoking cessation therapy in Australian and New Zealand intensive care units: a multicentre point prevalence study. Critical Care and Resuscitation. 20(1). 68–73. 1 indexed citations
15.
Bailey, Michael, Rinaldo Bellomo, Peter Stow, et al.. (2016). Insurance status and mortality in critically ill patients. Critical Care and Resuscitation. 18(1). 43–e11. 9 indexed citations
16.
McAlister, Scott, et al.. (2016). The Environmental footprint of morphine: a life cycle assessment from opium poppy farming to the packaged drug. BMJ Open. 6(10). e013302–e013302. 56 indexed citations
17.
McGain, Forbes, Graham Moore, & Jim Black. (2016). Steam sterilisation’s energy and water footprint. Australian Health Review. 41(1). 26–32. 37 indexed citations
18.
Douglas, James, et al.. (2014). Non-English speaking is a predictor of survival after admission to intensive care. Journal of Critical Care. 29(5). 769–774. 7 indexed citations
19.
McGain, Forbes, et al.. (2012). Workplace Sustainability. Anesthesia & Analgesia. 114(5). 1134–1139. 42 indexed citations
20.
Bellomo, Rinaldo, et al.. (2008). Pilot randomised double-blind controlled trial of high-dose spironolactone in critically ill patients receiving a frusemide infusion. Critical Care and Resuscitation. 10(4). 306–311. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026